Literature DB >> 1437327

Intensive care course and outcome of patients infected with respiratory syncytial virus.

M Stretton1, S J Ajizian, I Mitchell, C J Newth.   

Abstract

PICU admissions of 97 children positive for respiratory syncytial virus on fluorescent antibody screening were reviewed; 68% of 44 patients without history of preceding disease (Group I) and 79% of 53 patients with preceding pulmonary, cardiac, or other disease (Group II) required ventilation. In Group I ventilated children weighted significantly less (P = 0.001) and were of lower chronological (P = 0.02) and post-conceptional ages (P = 0.02) than those not ventilated. Eighteen infants ventilated for apnea weighted significantly less (P = 0.003), were more often born at less than or equal to 37 weeks gestation (P = 0.001) and were at lower post-conceptional age than 11 infants ventilated for progressive respiratory deterioration. There was no significant difference in mean weight, chronological age, post-conceptional age, CO2, or pH between 12 admissions with BPD who required ventilation for RSV infection and 5 who did not require ventilation. Ribavirin administration to five ventilated patients with BPD did not significantly alter the duration of intubation of PICU stay. Six patients with cardiac disease required longer periods of ventilation than others (Group I, P = 0.001; all others in Group II, P = 0.04). No deaths occurred in Group I, while 6 of 53 (11%) patients in Group II died. In this series immuno compromise placed patients at greatest risk of dying. Mechanical ventilation can be safely managed in previously healthy, RSV infected infants and should be initiated before significant cardiorespiratory compromise arises.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437327     DOI: 10.1002/ppul.1950130304

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  11 in total

Review 1.  Evidence based treatment of bronchiolitis.

Authors:  G R Sethi; Gaurav Nagar
Journal:  Indian J Pediatr       Date:  2004-08       Impact factor: 1.967

Review 2.  Management of acute bronchiolitis.

Authors:  K Rakshi; J M Couriel
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

3.  Detection of human respiratory syncytial virus in respiratory samples by LightCycler reverse transcriptase PCR.

Authors:  David M Whiley; Melanie W Syrmis; Ian M Mackay; Theo P Sloots
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 4.  Respiratory syncytial virus infection in children with congenital heart disease: a review.

Authors:  D E Fixler
Journal:  Pediatr Cardiol       Date:  1996 May-Jun       Impact factor: 1.655

Review 5.  Bronchiolitis. Origins and optimal management.

Authors:  M L Everard
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

Review 6.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus.

Authors:  J B M van Woensel; W M C van Aalderen; W de Weerd; N J G Jansen; J P J van Gestel; D G Markhorst; A J van Vught; A P Bos; J L L Kimpen
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

8.  The clinical picture presented by premature neonates infected with the respiratory syncytial virus.

Authors:  J Forster; R F Schumacher
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

9.  Chest radiological patterns predict the duration of mechanical ventilation in children with RSV infection.

Authors:  Parthak Prodhan; Sjirk J Westra; James Lin; Sarit Karni-Sharoor; Susan Regan; Natan Noviski
Journal:  Pediatr Radiol       Date:  2008-11-08

10.  Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo.

Authors:  Michele Y F Kong; Richard J Whitley; Ning Peng; Robert Oster; Trenton R Schoeb; Wayne Sullender; Namasivayam Ambalavanan; John Paul Clancy; Amit Gaggar; J Edwin Blalock
Journal:  Viruses       Date:  2015-07-30       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.